Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Lewis J Haddow, Tristan J Barber, Louise Breuer, Jonathan D Cartledge & Katherine Pierce. (2016) Evidence-based perspectives on the implementation of screening for neurocognitive impairment in HIV. Neurobehavioral HIV Medicine 7, pages 31-41.
Read now
Read now
Esther Fujiwara, Sara E. Tomlinson, Scot E. Purdon, M. John Gill & Christopher Power. (2015) Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV). Journal of Clinical and Experimental Neuropsychology 37:7, pages 733-750.
Read now
Read now
Bruce J Brew, Lachlan Gray, Sharon Lewin & Melissa Churchill. (2013) Is specific HIV eradication from the brain possible or needed?. Expert Opinion on Biological Therapy 13:3, pages 403-409.
Read now
Read now
Brandon C Dennis, Sidney A Houff, Dong Y Han & Frederick A Schmitt. (2011) Development of neurocognitive disorders in HIV/AIDS. Neurobehavioral HIV Medicine 3, pages 9-18.
Read now
Read now
Katrina A Morris, Nicholas WS Davies & Bruce J Brew. (2010) A guide to interpretation of neuroimmunological biomarkers in the combined antiretroviral therapy-era of HIV central nervous system disease. Neurobehavioral HIV Medicine 2, pages 59-72.
Read now
Read now
Articles from other publishers (47)
Erin E. Sundermann, Laura M. Campbell, Olivia Villers, Mark W. Bondi, Ben Gouaux, David P. Salmon, Douglas Galasko, Virawudh Soontornniyomkij, Ronald J. Ellis & David J. Moore. (2023) Alzheimer’s Disease Pathology in Middle Aged and Older People with HIV: Comparisons with Non-HIV Controls on a Healthy Aging and Alzheimer’s Disease Trajectory and Relationships with Cognitive Function. Viruses 15:6, pages 1319.
Crossref
Crossref
Leah H. Rubin, Luis B. Tovar-y-Romo & Norman J. Haughey. 2023. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders
501
524
.
Rowan Saloner, Natalie Savini, Scott L. Letendre, David J. Moore & Jessica L. Montoya. (2022) Neopterin Relates to Lifetime Depression in Older Adults With HIV on Suppressive Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 89:4, pages 454-461.
Crossref
Crossref
Sérgio M. de Almeida. 2022. Encyclopedia of Infection and Immunity. Encyclopedia of Infection and Immunity
302
312
.
Elena Irollo, Jared Luchetta, Chunta Ho, Bradley Nash & Olimpia Meucci. (2021) Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders. Cellular and Molecular Life Sciences 78:9, pages 4283-4303.
Crossref
Crossref
Amila Omeragic, Olanre Kayode, Md Tozammel Hoque & Reina Bendayan. (2020) Potential pharmacological approaches for the treatment of HIV-1 associated neurocognitive disorders. Fluids and Barriers of the CNS 17:1.
Crossref
Crossref
Nicoletta Ciccarelli. (2019) Considerations on nosology for HIV-associated neurocognitive disorders: it is time to update?. Infection 48:1, pages 37-42.
Crossref
Crossref
Sangsang Li, Yanfei Li, Bingpeng Deng, Jie Yan & Yong Wang. (2019) Identification of the Differentially Expressed Genes Involved in the Synergistic Neurotoxicity of an HIV Protease Inhibitor and Methamphetamine. Current HIV Research 17:4, pages 290-303.
Crossref
Crossref
Leah H. Rubin, Erin E. Sundermann & David J. Moore. (2019) The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer’s disease. Journal of NeuroVirology 25:5, pages 661-672.
Crossref
Crossref
Stephanie J. Bissel, Kate Gurnsey, Hank P. Jedema, Nicholas F. Smith, Guoji Wang, Charles W. Bradberry & Clayton A. Wiley. (2018) Aged Chinese-origin rhesus macaques infected with SIV develop marked viremia in absence of clinical disease, inflammation or cognitive impairment. Retrovirology 15:1.
Crossref
Crossref
Billy Tsima, Sarah Jane Ratcliffe, Robert Schnoll, Ian Frank, Dennis Larry Kolson & Robert Gross. (2018) Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?. Journal of the International Association of Providers of AIDS Care (JIAPAC) 17, pages 232595821876801.
Crossref
Crossref
Allison Ross Eckard, Julia C Rosebush, Mary Ann O'Riordan, Chanda C Graves, Ashley Alexander, Anita K Grover, S Thera Lee, Jakob G Habib, Joshua H Ruff, Ann Chahroudi & Grace A McComsey. (2016) Neurocognitive Dysfunction in HIV-Infected Youth: Investigating the Relationship with Immune Activation. Antiviral Therapy 22:8, pages 669-680.
Crossref
Crossref
Sam Nightingale & Alan Winston. (2017) Measuring and managing cognitive impairment in HIV. AIDS 31:Supplement 2, pages S165-S172.
Crossref
Crossref
Alex K. Bryant, David J. Moore, Tricia H. Burdo, Jessica R. Lakritz, Ben Gouaux, Virawudh Soontornniyomkij, Cristian L. Achim, Eliezer Masliah, Igor Grant, Andrew J. Levine & Ronald J. Ellis. (2017) Plasma soluble CD163 is associated with postmortem brain pathology in human immunodeficiency virus infection. AIDS 31:7, pages 973-979.
Crossref
Crossref
Khutso M. Mothapo, J. ten Oever, P. Koopmans, F. F. Stelma, S. Burm, J. Bajramovic, M. M. Verbeek, M. G. Olde Rikkert, M. G. Netea, G. Koopman & A. J. van der Ven. (2016) Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions. Journal of NeuroVirology 23:2, pages 250-259.
Crossref
Crossref
Katia FalascaMarcella RealeClaudio UcciferriMarta Di NicolaGiuseppe Di MartinoChiara D'AngeloSimona ColadonatoJacopo Vecchiet. (2017) Cytokines, Hepatic Fibrosis, and Antiretroviral Therapy Role in Neurocognitive Disorders HIV Related. AIDS Research and Human Retroviruses 33:3, pages 246-253.
Crossref
Crossref
Jacqueline Ellero, Michal Lubomski & Bruce Brew. (2017) Interventions for Neurocognitive Dysfunction. Current HIV/AIDS Reports 14:1, pages 8-16.
Crossref
Crossref
Luba Sominsky & Deborah Hodgson. 2017. Global Virology II - HIV and NeuroAIDS. Global Virology II - HIV and NeuroAIDS
229
256
.
Julia A. Najera, Eduardo A. Bustamante, Nikki Bortell, Brenda Morsey, Howard S. Fox, Timothy Ravasi & Maria Cecilia Garibaldi Marcondes. (2016) Methamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targets. BMC Immunology 17:1.
Crossref
Crossref
Sérgio M. de Almeida, Indianara Rotta, Clea E. Ribeiro, Davey Smith, Ruiyi Wang, Jennifer Judicello, Michael Potter, Florin Vaida, Scott Letendre & Ronald J. Ellis. (2016) Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection. Journal of Neuroimmunology 301, pages 41-48.
Crossref
Crossref
Sam Nightingale, Benedict D. Michael, Martin Fisher, Alan Winston, Mark Nelson, Steven Taylor, Andrew Ustianowski, Jonathan Ainsworth, Richard Gilson, Lewis Haddow, Edmund Ong, Clifford Leen, Jane Minton, Frank Post, Apostolos Beloukas, Ray Borrow, Munir Pirmohamed, Anna Maria Geretti, Saye Khoo & Tom Solomon. (2016) CSF/plasma HIV-1 RNA discordance even at low levels is associated with up-regulation of host inflammatory mediators in CSF. Cytokine 83, pages 139-146.
Crossref
Crossref
Thomas M. Gates, Lucette A. Cysique, Krista J. Siefried, Joga Chaganti, Kirsten J. Moffat & Bruce J. Brew. (2016) Maraviroc-intensified combined antiretroviral therapy improves cognition in virally suppressed HIV-associated neurocognitive disorder. AIDS 30:4, pages 591-600.
Crossref
Crossref
Michael R. KeeganSeetharamaiah ChittiprolScott L. LetendreAlan WinstonDietmar FuchsAdriano BoassoJennifer IudicelloRonald J. Ellis. (2016) Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment among HIV-infected Individuals. International Journal of Tryptophan Research 9, pages IJTR.S36464.
Crossref
Crossref
Giovanni Guaraldi, André Fragoso Gomes & Ana Rita Silva. 2016. Managing the Older Adult Patient with HIV. Managing the Older Adult Patient with HIV
19
52
.
Sabyasachi Dash, Muthukumar Balasubramaniam, Fernando Villalta, Chandravanu Dash & Jui Pandhare. (2015) Impact of cocaine abuse on HIV pathogenesis. Frontiers in Microbiology 6.
Crossref
Crossref
Julia L. Drewes, Kelly A. Meulendyke, Zhaohao Liao, Kenneth W. Witwer, Lucio Gama, Ceereena Ubaida-Mohien, Ming Li, Francesca M. Notarangelo, Patrick M. Tarwater, Robert Schwarcz, David R. Graham & M. Christine Zink. (2015) Quinolinic acid/tryptophan ratios predict neurological disease in SIV-infected macaques and remain elevated in the brain under cART. Journal of NeuroVirology 21:4, pages 449-463.
Crossref
Crossref
Yan Li, Amanda Eskelund, Hua Zhou, David Budac, Connie Sánchez & Maria Gulinello. (2015) Behavioral Deficits Are Accompanied by Immunological and Neurochemical Changes in a Mouse Model for Neuropsychiatric Lupus (NP-SLE). International Journal of Molecular Sciences 16:12, pages 15150-15171.
Crossref
Crossref
Sérgio Monteiro de Almeida. (2015) Cerebrospinal fluid analysis in the HIV infection and compartmentalization of HIV in the central nervous system. Arquivos de Neuro-Psiquiatria 73:7, pages 624-629.
Crossref
Crossref
Jennifer L. Lyons, Luis B. Tovar-y-Romo, Kiran T. Thakur, Justin C. McArthur & Norman J. Haughey. 2015. Neurobiology of Brain Disorders. Neurobiology of Brain Disorders
444
466
.
Miriam Estébanez, Natalia Stella-Ascariz, Jesús Mingorance, Ignacio Pérez-Valero, Alicia González-Baeza, Carmen Bayón, Botond Lakatos, Alberto Borobia, Francisco Arnalich & José R. Arribas. (2014) A Comparative Study of Neurocognitively Impaired Patients Receiving Protease Inhibitor Monotherapy or Triple-Drug Antiretroviral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 67:4, pages 419-423.
Crossref
Crossref
Sam Nightingale, Alan Winston, Scott Letendre, Benedict D Michael, Justin C McArthur, Saye Khoo & Tom Solomon. (2014) Controversies in HIV-associated neurocognitive disorders. The Lancet Neurology 13:11, pages 1139-1151.
Crossref
Crossref
Jeffrey McDonnell, Lewis Haddow, Marina Daskalopoulou, Fiona Lampe, Andrew Speakman, Richard Gilson, Andrew Phillips, Lorraine Sherr, Sonali Wayal, John Harrison, Andrea Antinori, Paul Maruff, Adrian Schembri, Margaret Johnson, Simon Collins & Alison Rodger. (2014) Minimal Cognitive Impairment in UK HIV-Positive Men Who Have Sex With Men. JAIDS Journal of Acquired Immune Deficiency Syndromes 67:2, pages 120-127.
Crossref
Crossref
Anton Pozniak, Simon Rackstraw, Jane Deayton, Tristan Barber, Steve Taylor, Hadi Manji, Diane Melvin, Michelle Croston, Sam Nightingale, Ranubabu Kulasegaram, Mervi Pitkanen & Alan Winston. (2014) Hiv-Associated Neurocognitive Disease: Case Studies and Suggestions for Diagnosis and Management in Different Patient Subgroups. Antiviral Therapy 19:1, pages 1-13.
Crossref
Crossref
Montserrat Sanmarti, Laura Ibáñez, Sonia Huertas, Dolors Badenes, David Dalmau, Mark Slevin, Jerzy Krupinski, Aurel Popa-Wagner & Angeles Jaen. (2014) HIV-associated neurocognitive disorders. Journal of Molecular Psychiatry 2:1, pages 2.
Crossref
Crossref
Edana Cassol, Vikas Misra, Susan Morgello & Dana Gabuzda. (2013) Applications and Limitations of Inflammatory Biomarkers for Studies on Neurocognitive Impairment in HIV Infection. Journal of Neuroimmune Pharmacology 8:5, pages 1087-1097.
Crossref
Crossref
Sergio Monteiro de Almeida. (2013) Cognitive impairment and major depressive disorder in HIV infection and cerebrospinal fluid biomarkers. Arquivos de Neuro-Psiquiatria 71:9B, pages 689-692.
Crossref
Crossref
Jennifer L. McGuire & Steven D. Douglas. (2013) Neuroimmune Dysregulation in HIV-Associated Neurocognitive Disorders. Psychiatric Annals 43:5, pages 217-222.
Crossref
Crossref
L. B. Avery, N. Sacktor, J. C. McArthur & C. W. Hendrix. (2013) Protein-Free Efavirenz Concentrations in Cerebrospinal Fluid and Blood Plasma Are Equivalent: Applying the Law of Mass Action To Predict Protein-Free Drug Concentration. Antimicrobial Agents and Chemotherapy 57:3, pages 1409-1414.
Crossref
Crossref
Renaud A. Du Pasquier, Samantha Jilek, Malela Kalubi, Sabine Yerly, Christoph A. Fux, Christine Gutmann, Alexia Cusini, Huldrych F. Günthard, Matthias Cavassini & Pietro L. Vernazza. (2013) Marked increase of the astrocytic marker S100B in the cerebrospinal fluid of HIV-infected patients on LPV/r-monotherapy. AIDS 27:2, pages 203-210.
Crossref
Crossref
David Ellison, Seth Love, Leila Chimelli, Brian N. Harding, James S. Lowe, Harry V. Vinters, Sebastian Brandner & William H. Yong. 2013. Neuropathology. Neuropathology
327
355
.
Anupa Kamat, Jennifer L. Lyons, Vikas Misra, Hajime Uno, Susan Morgello, Elyse J. Singer & Dana Gabuzda. (2012) Monocyte Activation Markers in Cerebrospinal Fluid Associated With Impaired Neurocognitive Testing in Advanced HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 60:3, pages 234-243.
Crossref
Crossref
Jennifer L Lyons, Hajime Uno, Petronela Ancuta, Anupa Kamat, David J Moore, Elyse J Singer, Susan Morgello & Dana Gabuzda. (2011) Plasma sCD14 Is a Biomarker Associated With Impaired Neurocognitive Test Performance in Attention and Learning Domains in HIV Infection. JAIDS Journal of Acquired Immune Deficiency Syndromes 57:5, pages 371-379.
Crossref
Crossref
Nicholas W. S. Davies & Bruce J Brew. 2011. Case Studies in Dementia. Case Studies in Dementia
180
187
.
Toni K. Roberts, Eliseo A. Eugenin, Susan Morgello, Janice E. Clements, M. Christine Zink & Joan W. Berman. (2010) PrPC, the Cellular Isoform of the Human Prion Protein, Is a Novel Biomarker of HIV-Associated Neurocognitive Impairment and Mediates Neuroinflammation. The American Journal of Pathology 177:4, pages 1848-1860.
Crossref
Crossref
Justin C McArthur & Bruce J Brew. (2010) HIV-associated neurocognitive disorders: is there a hidden epidemic?. AIDS 24:9, pages 1367-1370.
Crossref
Crossref
Justin C. McArthur, Joseph Steiner, Ned Sacktor & Avi Nath. (2010) Human immunodeficiency virus‐associated neurocognitive disorders: Mind the gap. Annals of Neurology 67:6, pages 699-714.
Crossref
Crossref
Scott L. Letendre, J. Allen McCutchan & Ronald J. Ellis. (2008) Better Biomarkers Are Needed to Improve the Management of the Neurologic Complications of HIV Infection. Clinical Infectious Diseases 46:12, pages 1940-1941.
Crossref
Crossref